David J. Straus

Low-Dose Compared with Standard-Dose m-BACOD Chemotherapy for Non-Hodgkin's Lymphoma Associated with Human Immunodeficiency Virus Infection

Lawrence D. Kaplan, David J. Straus, Marcia A. Testa et al. · New England Journal of Medicine · 1997 · 378 citations · Full text

Medicine, Hematology, Oncology +17

Acupuncture for Postchemotherapy Fatigue: A Phase II Study

Andrew J. Vickers, David J. Straus, Bertha L. Fearon et al. · Journal of Clinical Oncology · 2004 · 198 citations

Medicine, Oncology, Pharmacotherapy +13

Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Group protocol 142--low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor. National Institute of Allergy and Infectious Diseases.

David J. Straus, J. Huang, Marcia A. Testa et al. · Journal of Clinical Oncology · 1998 · 161 citations

Medicine, Oncology, Pharmacology +16

Treatment of acute lymphoblastic leukemia in adults: results of the L-10 and L-10M protocols.

Peter Schauer, Z Arlin, Roland Mertelsmann et al. · Journal of Clinical Oncology · 1983 · 154 citations

Medicine, Oncology, Pharmacology +16

Treatment of patients with advanced malignant lymphoma using gallium nitrate administered as a seven-day continuous infusion

Raymond P. Warrell, Craig J. Coonley, David J. Straus et al. · Cancer · 1983 · 134 citations

Medicine, Oncology, Pharmacology +13